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BACKGROUND Reoperative procedure for the substitution of failed
mitral bioprosthesis is a procedure that might involve considerable
risk. In some special cases with selected risk factors, mortality is high
and might even contraindicate the procedure. The minimally invasive
valve-in-valve transcatheter transapical mitral valve implant offers an
alternative, reducing morbidity and mortality. The objective of this
paper is the evaluation of these implants using the Braile Inovare
prosthesis.
METHODS The transcatheter balloon-expandable Braile Inovare
prosthesis was used in 12 cases, with an average EuroSCORE of 20.1%.
Procedures were performed in a hybrid operative room, under ﬂuo-
roscopic and echocardiographic control. Through left mini-
thoracotomy, the prostheses were implanted through the cardiac
apex, under rapid pacing. Seriated echocardiographic and clinical
controls were performed. Follow-up varied from 1 to 30 months.
RESULTS Correct prosthesis release took place in all cases. In one
case, there was need for right lateral thoracotomy for the release of an
embolized prosthesis. There was no operative mortality. 30 day
mortality was of one case (8.3%). Ejection fraction showed a signiﬁ-
cant improvement after the 7th post-operative day and the aortic
gradient also showed a reduction. Residual mitral regurgitation was
not present. There was no peripheral vascular complication or com-
plete atrioventricular block.
CONCLUSIONS The mitral valve-in-valve transcatheter implant in
failed bioprosthesis is a safe procedure, with low morbidity and
mortality. This possibility might alter prosthesis selection in the initial
surgical prosthesis selection, favoring bioprostheses.
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BACKGROUND Percutaneous mitral valve edge-to-edge repair using
the MitraClip system has been widespread for signiﬁcant mitral
regurgitation (MR) patients with high surgical risk. Learning curve isan important concern for the institute which introduce the MitraClip
procedure in the future. In this study, the effect of learning curve on
the procedural results and recurrent MR was investigated.
METHODS From November 2005 to October 2013, 174 patients un-
derwent the MitraClip procedure in our institute. These patients were
classiﬁed into ﬁrst 50 patients (period 1), second 50 patients (period
2), and the other 74 patients (period 3), and learning curve was eval-
uated by comparison of procedural results and the subsequent
recurrence of MR between the 3 groups. All MitraClip procedures were
performed by or under the supervision of a single operator (S. Kar).
RESULTS Fluoroscopic time was 45.1  18.2 min in period 1, 42.7 
23.1 min in period 2, and 34.8  13.8 min in period 3, and signiﬁcantly
decreased from period 1 to period 3 (p¼0.007). The number of clips
was 1.38  0.57 in period 1, 1.48  0.51 in period 2, and 1.60  0.52 in
period 3 (p¼0.07). Although acute procedural success (residual MR
</¼2þ immediately after the procedure) was similarly achieved in the
3 groups (94.0% vs. 94.0% vs. 98.6%, p¼0.31), the distribution of re-
sidual MR grade after the procedure was signiﬁcantly better in period
3 than in period 1 (p¼0.04). Among patients with acute procedural
success, recurrent MR within 1 year was observed more frequently in
period 1 (38.3%) than in period 2 (10.6%, p¼0.002) and period 3 (15.3%,
p¼0.004).
CONCLUSIONS Learning curve of the MitraClip procedure was
observed in terms of procedural quality and device durability. When
starting the MitraClip program, these ﬁndings should be considered.
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BACKGROUND Targeted transseptal (TS) puncture is an essential
technique for many structural heart interventions. Spatial accuracy of
standard versus radiofrequency (RF) needles has not previously been
reported.
METHODS Consecutive patients undergoing left-sided structural
heart interventions requiring TS puncture were included in an
ongoing registry. The BRK needle (St Jude Med) paired with Mullins
sheath (Medtronic) was used alternately with RF needle (Baylis Med)
paired with SL1 Sheath (St Jude Med). Procedural times were: (1)
withdrawing the TS system from the SVC and positioning at the
intended TS site; (2) time to cross septum once site was selected; (3)
time to advance the sheath across the septum. Transesophageal
echocardiographic (TEE) measurements of intended versus ﬁnal TS
crossing site on the septum were obtained. These measurements were
made from reproducible edges of the visible portions of the fossa
ovalis and/or interatrial septum to the TS site in bicaval and short axis
(SAX) TEE views both pre and post TS puncture. Pre puncture and
maximal tenting of the septum were also quantiﬁed.
RESULTS 25 patients underwent standard needle and 27 RF needle TS
access. 2 patients crossed over from the standard needle group to the
RF group due to inability to puncture. Data is reported in an “as
treated” analysis. Left-sided heart interventions included the Mitra-
Clip (N¼35), Watchman (N¼9), and Lariat (N¼7) procedures and
percutaneous balloon mitral valvuloplasty (N¼1). The principal ﬁnd-
ings are shown in the Table. TS procedural times signiﬁcantly favored
the RF needle for time from septum to puncture. Both standard and
RF access yielded accurate crossing technique with no statistical
differences between the intended and actual crossing site. Maximal
tenting was signiﬁcantly less with the RF needle. Few patients had
challenging atrial anatomy such as atrial septal aneurysm, thickened
septum primum or prior TS attempts. 2 patients in the standard arm
required the mandril wire for assistance to cross. There were no
major complications.
